{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:25Z","timestamp":1788307225142,"version":"build-2803163510"},"publisher-location":"Cham","reference-count":61,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783031571640","type":"print"},{"value":"9783031571657","type":"electronic"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-3-031-57165-7_18","type":"book-chapter","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T07:02:03Z","timestamp":1716793323000},"page":"289-300","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Current Status of Vaccine Development for Monkeypox Virus"],"prefix":"10.1007","author":[{"given":"Amber","family":"Rastogi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"key":"18_CR1","doi-asserted-by":"publisher","unstructured":"Abdi SAH, Ali A, Sayed SF et al (2022) Multi-epitope-based vaccine candidate for monkeypox: an in silico approach. Vaccines 10. https:\/\/doi.org\/10.3390\/VACCINES10091564","DOI":"10.3390\/VACCINES10091564"},{"key":"18_CR2","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/S1473-3099(22)00228-6","volume":"22","author":"H Adler","year":"2022","unstructured":"Adler H, Gould S, Hine P et al (2022) Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis 22:1153\u20131162. https:\/\/doi.org\/10.1016\/S1473-3099(22)00228-6","journal-title":"Lancet Infect Dis"},{"key":"18_CR3","doi-asserted-by":"publisher","first-page":"E30406","DOI":"10.1097\/MD.0000000000030406","volume":"101","author":"N Adnan","year":"2022","unstructured":"Adnan N, Haq ZU, Malik A et al (2022) Human monkeypox virus: an updated review. Medicine (baltimore) 101:E30406. https:\/\/doi.org\/10.1097\/MD.0000000000030406","journal-title":"Medicine (baltimore)"},{"key":"18_CR61","doi-asserted-by":"publisher","unstructured":"Aiman S, Alhamhoom Y, Ali F, Rahman N, Rastrelli L, Khan A, Farooq QUA, Ahmed A, Khan A, Li C (2022) Multi-epitope chimeric vaccine design against emerging Monkeypox virus via reverse vaccinology techniques- a bioinformatics and immunoinformatics approach. Front Immunol 13:985450. https:\/\/doi.org\/10.3389\/fimmu.2022.985450. PMID: 36091024; PMCID: PMC9452969","DOI":"10.3389\/fimmu.2022.985450"},{"key":"18_CR4","doi-asserted-by":"publisher","unstructured":"Akhtar N, Kaushik V, Grewal RK et al (2022) Immunoinformatics-aided design of a peptide based multiepitope vaccine targeting glycoproteins and membrane proteins against monkeypox virus. Viruses 14.https:\/\/doi.org\/10.3390\/V14112374","DOI":"10.3390\/V14112374"},{"key":"18_CR5","doi-asserted-by":"publisher","unstructured":"Al-Musa A, Chou J, LaBere B (2022) The resurgence of a neglected orthopoxvirus: Immunologic and clinical aspects of monkeypox virus infections over the past six decades. Clin Immunol 243.https:\/\/doi.org\/10.1016\/J.CLIM.2022.109108","DOI":"10.1016\/J.CLIM.2022.109108"},{"key":"18_CR6","doi-asserted-by":"publisher","unstructured":"Aziz S, Almajhdi FN, Waqas M et al (2022) Contriving multi-epitope vaccine ensemble for monkeypox disease using an immunoinformatics approach. Front Immunol 13. https:\/\/doi.org\/10.3389\/FIMMU.2022.1004804","DOI":"10.3389\/FIMMU.2022.1004804"},{"key":"18_CR7","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1128\/JVI.02244-07","volume":"82","author":"MR-E-I Benhnia","year":"2008","unstructured":"Benhnia MR-E-I, McCausland MM, Su H-P et al (2008) Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine. J Virol 82:3751\u20133768. https:\/\/doi.org\/10.1128\/JVI.02244-07","journal-title":"J Virol"},{"key":"18_CR8","doi-asserted-by":"publisher","unstructured":"Bhattacharya M, Chatterjee S, Nag S et al (2022) Designing, characterization, and immune stimulation of a novel multi-epitopic peptide-based potential vaccine candidate against monkeypox virus through screening its whole genome encoded proteins: an immunoinformatics approach. Travel Med Infect Dis 50. https:\/\/doi.org\/10.1016\/J.TMAID.2022.102481","DOI":"10.1016\/J.TMAID.2022.102481"},{"key":"18_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.4269\/AJTMH.1977.26.273","volume":"26","author":"JG Breman","year":"1977","unstructured":"Breman JG, Nakano JH, Coffi E et al (1977) Human poxvirus disease after smallpox eradication. Am J Trop Med Hyg 26:273\u2013281. https:\/\/doi.org\/10.4269\/AJTMH.1977.26.273","journal-title":"Am J Trop Med Hyg"},{"key":"18_CR10","doi-asserted-by":"publisher","unstructured":"Bunge EM, Hoet B, Chen L et al (2022) The changing epidemiology of human monkeypox\u2014a potential threat? A systematic review. PLoS Negl Trop Dis 16. https:\/\/doi.org\/10.1371\/JOURNAL.PNTD.0010141","DOI":"10.1371\/JOURNAL.PNTD.0010141"},{"key":"18_CR11","unstructured":"CDC, NCIRD (2012) Selected discontinued U.S. vaccines"},{"key":"18_CR12","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1128\/JVI.72.2.1577-1585.1998","volume":"72","author":"C-S Chung","year":"1998","unstructured":"Chung C-S, Hsiao J-C, Chang Y-S, Chang W (1998) A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate. J Virol 72:1577\u20131585. https:\/\/doi.org\/10.1128\/JVI.72.2.1577-1585.1998","journal-title":"J Virol"},{"key":"18_CR13","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/S0140-6736(47)91671-1","volume":"1","author":"AW Downie","year":"1947","unstructured":"Downie AW, Dumbell KR (1947) Survival of variola virus in dried exudate and crusts from smallpox patients. Lancet (London, England) 1:550\u2013553. https:\/\/doi.org\/10.1016\/S0140-6736(47)91671-1","journal-title":"Lancet (London, England)"},{"key":"18_CR14","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/NATURE02331","volume":"428","author":"PL Earl","year":"2004","unstructured":"Earl PL, Americo JL, Wyatt LS et al (2004) Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox. Nature 428:182\u2013185. https:\/\/doi.org\/10.1038\/NATURE02331","journal-title":"Nature"},{"key":"18_CR15","doi-asserted-by":"publisher","first-page":"10889","DOI":"10.1073\/PNAS.0804985105","volume":"105","author":"PL Earl","year":"2008","unstructured":"Earl PL, Americo JL, Wyatt LS et al (2008) Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus. Proc Natl Acad Sci U S A 105:10889\u201310894. https:\/\/doi.org\/10.1073\/PNAS.0804985105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"18_CR16","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S0196-6553(03)00652-7","volume":"31","author":"CE Edmiston","year":"2003","unstructured":"Edmiston CE, Graham MB, Wilson PJ, Grahn B (2003) The monkeypox virus outbreak: reflections from the frontlines. Am J Infect Control 31:382\u2013384. https:\/\/doi.org\/10.1016\/S0196-6553(03)00652-7","journal-title":"Am J Infect Control"},{"key":"18_CR17","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3201\/EID2505.190076","volume":"25","author":"N Erez","year":"2019","unstructured":"Erez N, Achdout H, Milrot E et al (2019) Diagnosis of Imported Monkeypox, Israel, 2018. Emerg Infect Dis 25:980\u2013983. https:\/\/doi.org\/10.3201\/EID2505.190076","journal-title":"Emerg Infect Dis"},{"key":"18_CR18","unstructured":"FDA, CDER, PURDIEF (2013) Guidance for industry labeling for human prescription drug and biological products-implementing the PLR Content and format requirements guidance for industry labeling for human prescription drug and biological products-implementing the PLR content and format requirements labeling contains nonbinding recommendations"},{"key":"18_CR19","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.3201\/EID1610.100713","volume":"16","author":"P Formenty","year":"2010","unstructured":"Formenty P, Muntasir MO, Damon I et al (2010) Human monkeypox outbreak caused by novel virus belonging to Congo Basin clade, Sudan, 2005. Emerg Infect Dis 16:1539\u20131545. https:\/\/doi.org\/10.3201\/EID1610.100713","journal-title":"Emerg Infect Dis"},{"key":"18_CR20","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/J.VACCINE.2008.11.079","volume":"27","author":"SE Frey","year":"2009","unstructured":"Frey SE, Newman FK, Kennedy JS et al (2009) Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adults. Vaccine 27:1637\u20131644. https:\/\/doi.org\/10.1016\/J.VACCINE.2008.11.079","journal-title":"Vaccine"},{"key":"18_CR21","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.1016\/J.VACCINE.2015.06.075","volume":"33","author":"SE Frey","year":"2015","unstructured":"Frey SE, Wald A, Edupuganti S et al (2015) Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-na\u00efve subjects. Vaccine 33:5225\u20135234. https:\/\/doi.org\/10.1016\/J.VACCINE.2015.06.075","journal-title":"Vaccine"},{"key":"18_CR22","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2022.2141887","author":"C Hayat","year":"2022","unstructured":"Hayat C, Shahab M, Khan SA et al (2022) Design of a novel multiple epitope-based vaccine: an immunoinformatics approach to combat monkeypox. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2022.2141887","journal-title":"J Biomol Struct Dyn"},{"key":"18_CR23","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/OXFORDJOURNALS.BMB.A011720","volume":"54","author":"DL Heymann","year":"1998","unstructured":"Heymann DL, Szczeniowski M, Esteves K (1998) Re-emergence of monkeypox in Africa: a review of the past six years. Br Med Bull 54:693\u2013702. https:\/\/doi.org\/10.1093\/OXFORDJOURNALS.BMB.A011720","journal-title":"Br Med Bull"},{"key":"18_CR24","doi-asserted-by":"publisher","first-page":"8374","DOI":"10.1128\/JVI.72.10.8374-8379.1998","volume":"72","author":"J-C Hsiao","year":"1998","unstructured":"Hsiao J-C, Chung C-S, Chang W (1998) Cell surface proteoglycans are necessary for A27L protein-mediated cell fusion: identification of the N-terminal region of A27L protein as the glycosaminoglycan-binding domain. J Virol 72:8374\u20138379. https:\/\/doi.org\/10.1128\/JVI.72.10.8374-8379.1998","journal-title":"J Virol"},{"key":"18_CR25","doi-asserted-by":"publisher","first-page":"8750","DOI":"10.1128\/JVI.73.10.8750-8761.1999","volume":"73","author":"J-C Hsiao","year":"1999","unstructured":"Hsiao J-C, Chung C-S, Chang W (1999) Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells. J Virol 73:8750\u20138761. https:\/\/doi.org\/10.1128\/JVI.73.10.8750-8761.1999","journal-title":"J Virol"},{"key":"18_CR26","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1086\/498115","volume":"41","author":"GD Huhn","year":"2005","unstructured":"Huhn GD, Bauer AM, Yorita K et al (2005) Clinical characteristics of human monkeypox, and risk factors for severe disease. Clin Infect Dis 41:1742\u20131751. https:\/\/doi.org\/10.1086\/498115","journal-title":"Clin Infect Dis"},{"key":"18_CR27","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/J.JMII.2022.08.016","volume":"55","author":"YP Hung","year":"2022","unstructured":"Hung YP, Lee CC, Lee JC et al (2022) A brief on new waves of monkeypox and vaccines and antiviral drugs for monkeypox. J Microbiol Immunol Infect 55:795\u2013802. https:\/\/doi.org\/10.1016\/J.JMII.2022.08.016","journal-title":"J Microbiol Immunol Infect"},{"key":"18_CR28","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1093\/OXFORDJOURNALS.AJE.A114328","volume":"123","author":"Z Jezek","year":"1986","unstructured":"Jezek Z, Arita I, Mutombo M et al (1986) Four generations of probable person-to-person transmission of human monkeypox. Am J Epidemiol 123:1004\u20131012. https:\/\/doi.org\/10.1093\/OXFORDJOURNALS.AJE.A114328","journal-title":"Am J Epidemiol"},{"key":"18_CR29","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/INFDIS\/156.2.293","volume":"156","author":"Z Je\u017eek","year":"1987","unstructured":"Je\u017eek Z, Szczeniowski M, Paluku KM, Mutombo M (1987) Human monkeypox: clinical features of 282 patients. J Infect Dis 156:293\u2013298. https:\/\/doi.org\/10.1093\/INFDIS\/156.2.293","journal-title":"J Infect Dis"},{"key":"18_CR30","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3201\/EID2002.130118","volume":"20","author":"JR Kugelman","year":"2014","unstructured":"Kugelman JR, Johnston SC, Mulembakani PM et al (2014) Genomic variability of monkeypox virus among humans, Democratic Republic of the Congo. Emerg Infect Dis 20:232\u2013239. https:\/\/doi.org\/10.3201\/EID2002.130118","journal-title":"Emerg Infect Dis"},{"key":"18_CR31","doi-asserted-by":"publisher","unstructured":"Kumar N, Acharya A, Gendelman HE, Byrareddy SN (2022) The 2022 outbreak and the pathobiology of the monkeypox virus. J Autoimmun 131. https:\/\/doi.org\/10.1016\/J.JAUT.2022.102855","DOI":"10.1016\/J.JAUT.2022.102855"},{"key":"18_CR32","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1093\/INFDIS\/171.4.788","volume":"171","author":"JP Lalezari","year":"1995","unstructured":"Lalezari JP, Drew WL, Glutzer E et al (1995) (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I\/II study of a novel antiviral nucleotide analogue. J Infect Dis 171:788\u2013796. https:\/\/doi.org\/10.1093\/INFDIS\/171.4.788","journal-title":"J Infect Dis"},{"key":"18_CR33","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1053\/j.spid.2004.09.001","volume":"15","author":"BL Ligon","year":"2004","unstructured":"Ligon BL (2004) Monkeypox: a review of the history and emergence in the Western hemisphere. Semin Pediatr Infect Dis 15:280\u2013287. https:\/\/doi.org\/10.1053\/j.spid.2004.09.001","journal-title":"Semin Pediatr Infect Dis"},{"key":"18_CR34","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1099\/VIR.0.81215-0","volume":"86","author":"AM Likos","year":"2005","unstructured":"Likos AM, Sammons SA, Olson VA et al (2005) A tale of two clades: monkeypox viruses. J Gen Virol 86:2661\u20132672. https:\/\/doi.org\/10.1099\/VIR.0.81215-0","journal-title":"J Gen Virol"},{"key":"18_CR35","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1128\/JVI.74.7.3353-3365.2000","volume":"74","author":"C-L Lin","year":"2000","unstructured":"Lin C-L, Chung C-S, Heine HG, Chang W (2000) Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo. J Virol 74:3353\u20133365. https:\/\/doi.org\/10.1128\/JVI.74.7.3353-3365.2000","journal-title":"J Virol"},{"key":"18_CR36","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/S41577-022-00775-4","volume":"22","author":"FM Lum","year":"2022","unstructured":"Lum FM, Torres-Ruesta A, Tay MZ et al (2022) Monkeypox: disease epidemiology, host immunity and clinical interventions. Nat Rev Immunol 22:597\u2013613. https:\/\/doi.org\/10.1038\/S41577-022-00775-4","journal-title":"Nat Rev Immunol"},{"key":"18_CR37","doi-asserted-by":"publisher","unstructured":"Luong Nguyen LB, Ghosn J, Durier C, et al (2022) A prospective national cohort evaluating ring MVA vaccination as post-exposure prophylaxis for monkeypox. Nat Med 28. https:\/\/doi.org\/10.1038\/D41591-022-00077-1","DOI":"10.1038\/D41591-022-00077-1"},{"key":"18_CR38","unstructured":"Marennikova SS, Seluhina EM, Mal\u2019ceva NN, et al (1972) Isolation and properties of the causal agent of a new variola-like disease (monkeypox) in man. Bull World Health Organ 46:599"},{"key":"18_CR39","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/J.VACCINE.2007.10.063","volume":"26","author":"KA Marriott","year":"2008","unstructured":"Marriott KA, Parkinson CV, Morefield SI et al (2008) Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge. Vaccine 26:581\u2013588. https:\/\/doi.org\/10.1016\/J.VACCINE.2007.10.063","journal-title":"Vaccine"},{"key":"18_CR40","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1093\/INFDIS\/JIX260","volume":"216","author":"PK Mbala","year":"2017","unstructured":"Mbala PK, Huggins JW, Riu-Rovira T et al (2017) Maternal and fetal outcomes among pregnant women with human monkeypox infection in the Democratic Republic of Congo. J Infect Dis 216:824\u2013828. https:\/\/doi.org\/10.1093\/INFDIS\/JIX260","journal-title":"J Infect Dis"},{"key":"18_CR41","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/NRMICRO1099","volume":"3","author":"G McFadden","year":"2005","unstructured":"McFadden G (2005) Poxvirus tropism. Nat Rev Microbiol 3:201\u2013213. https:\/\/doi.org\/10.1038\/NRMICRO1099","journal-title":"Nat Rev Microbiol"},{"key":"18_CR42","doi-asserted-by":"publisher","unstructured":"Molero-Abraham M, Glutting JP, Flower DR, et al (2015) EPIPOX: immunoinformatic characterization of the shared T-Cell epitome between variola virus and related pathogenic orthopoxviruses. J Immunol Res 2015.https:\/\/doi.org\/10.1155\/2015\/738020","DOI":"10.1155\/2015\/738020"},{"key":"18_CR43","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/DDDT.S3687","volume":"4","author":"A Nalca","year":"2010","unstructured":"Nalca A, Zumbrun EE (2010) ACAM2000: the new smallpox vaccine for United States Strategic National Stockpile. Drug Des Devel Ther 4:71\u201379. https:\/\/doi.org\/10.2147\/DDDT.S3687","journal-title":"Drug Des Devel Ther"},{"key":"18_CR44","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3201\/EID2704.203569","volume":"27","author":"PY Nguyen","year":"2021","unstructured":"Nguyen PY, Ajisegiri WS, Costantino V et al (2021) Reemergence of human monkeypox and declining population immunity in the context of urbanization, Nigeria, 2017\u20132020. Emerg Infect Dis 27:1007\u20131014. https:\/\/doi.org\/10.3201\/EID2704.203569","journal-title":"Emerg Infect Dis"},{"key":"18_CR45","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1056\/NEJMOA1817307","volume":"381","author":"PR Pittman","year":"2019","unstructured":"Pittman PR, Hahn M, Lee HS et al (2019) Phase 3 efficacy trial of Modified Vaccinia Ankara as a vaccine against smallpox. N Engl J Med 381:1897\u20131908. https:\/\/doi.org\/10.1056\/NEJMOA1817307","journal-title":"N Engl J Med"},{"key":"18_CR46","doi-asserted-by":"publisher","first-page":"16262","DOI":"10.1073\/PNAS.1005769107","volume":"107","author":"AW Rimoin","year":"2010","unstructured":"Rimoin AW, Mulembakani PM, Johnston SC et al (2010) Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proc Natl Acad Sci U S A 107:16262\u201316267. https:\/\/doi.org\/10.1073\/PNAS.1005769107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"18_CR47","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/14787210.2020.1819791","volume":"19","author":"AT Russo","year":"2021","unstructured":"Russo AT, Grosenbach DW, Chinsangaram J et al (2021) An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications. Expert Rev Anti Infect Ther 19:331\u2013344. https:\/\/doi.org\/10.1080\/14787210.2020.1819791","journal-title":"Expert Rev Anti Infect Ther"},{"key":"18_CR48","doi-asserted-by":"publisher","unstructured":"Saxena SK, Ansari S, Maurya VK et al (2023) Re-emerging human monkeypox: a major public-health debacle. J Med Virol 95. https:\/\/doi.org\/10.1002\/JMV.27902","DOI":"10.1002\/JMV.27902"},{"key":"18_CR49","doi-asserted-by":"publisher","unstructured":"Shantier SW, Mustafa MI, Abdelmoneim AH et al (2022) Novel multi epitope-based vaccine against monkeypox virus: vaccinomic approach. Sci Rep 12. https:\/\/doi.org\/10.1038\/S41598-022-20397-Z","DOI":"10.1038\/S41598-022-20397-Z"},{"key":"18_CR50","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0014-5793(01)03144-1","volume":"509","author":"SN Shchelkunov","year":"2001","unstructured":"Shchelkunov SN, Totmenin AV, Babkin IV et al (2001) Human monkeypox and smallpox viruses: genomic comparison. FEBS Lett 509:66\u201370. https:\/\/doi.org\/10.1016\/S0014-5793(01)03144-1","journal-title":"FEBS Lett"},{"key":"18_CR51","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1006\/viro.2002.1446","volume":"297","author":"SN Shchelkunov","year":"2002","unstructured":"Shchelkunov SN, Totmenin AV, Safronov PF et al (2002) Analysis of the monkeypox virus genome. Virology 297:172\u2013194. https:\/\/doi.org\/10.1006\/viro.2002.1446","journal-title":"Virology"},{"key":"18_CR52","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1099\/0022-1317-83-12-2915","volume":"83","author":"GL Smith","year":"2002","unstructured":"Smith GL, Vanderplasschen A, Law M (2002) The formation and function of extracellular enveloped vaccinia virus. J Gen Virol 83:2915\u20132931. https:\/\/doi.org\/10.1099\/0022-1317-83-12-2915","journal-title":"J Gen Virol"},{"key":"18_CR53","doi-asserted-by":"publisher","unstructured":"Suleman M, Rashid F, Ali S et al (2022) Immunoinformatic-based design of immune-boosting multiepitope subunit vaccines against monkeypox virus and validation through molecular dynamics and immune simulation. Front Immunol 13. https:\/\/doi.org\/10.3389\/FIMMU.2022.1042997","DOI":"10.3389\/FIMMU.2022.1042997"},{"key":"18_CR54","doi-asserted-by":"publisher","unstructured":"Swetha RG, Basu S, Ramaiah S, Anbarasu A (2022) Multi-epitope vaccine for monkeypox using pan-genome and reverse vaccinology approaches. Viruses 14.https:\/\/doi.org\/10.3390\/V14112504","DOI":"10.3390\/V14112504"},{"key":"18_CR55","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1128\/JVI.02089-12","volume":"87","author":"MB Townsend","year":"2013","unstructured":"Townsend MB, Keckler MS, Patel N et al (2013) Humoral immunity to smallpox vaccines and monkeypox virus challenge: proteomic assessment and clinical correlations. J Virol 87:900\u2013911. https:\/\/doi.org\/10.1128\/JVI.02089-12","journal-title":"J Virol"},{"key":"18_CR56","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2022.2125441","author":"A Ullah","year":"2022","unstructured":"Ullah A, Shahid FA, Haq MU et al (2022) An integrative reverse vaccinology, immunoinformatic, docking and simulation approaches towards designing of multi-epitopes based vaccine against monkeypox virus. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2022.2125441","journal-title":"J Biomol Struct Dyn"},{"issue":"Pt 4","key":"18_CR57","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1099\/0022-1317-79-4-877","volume":"79","author":"A Vanderplasschen","year":"1998","unstructured":"Vanderplasschen A, Hollinshead M, Smith GL (1998) Intracellular and extracellular vaccinia virions enter cells by different mechanisms. J Gen Virol 79(Pt 4):877\u2013887. https:\/\/doi.org\/10.1099\/0022-1317-79-4-877","journal-title":"J Gen Virol"},{"key":"18_CR58","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/BS.AIVIR.2016.07.001","volume":"97","author":"A Volz","year":"2017","unstructured":"Volz A, Sutter G (2017) Modified vaccinia virus Ankara: history, value in basic research, and current perspectives for vaccine development. Adv Virus Res 97:187\u2013243. https:\/\/doi.org\/10.1016\/BS.AIVIR.2016.07.001","journal-title":"Adv Virus Res"},{"key":"18_CR59","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1093\/INFDIS\/JIT105","volume":"207","author":"SR Walsh","year":"2013","unstructured":"Walsh SR, Wilck MB, Dominguez DJ et al (2013) Safety and immunogenicity of modified vaccinia Ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial. J Infect Dis 207:1888\u20131897. https:\/\/doi.org\/10.1093\/INFDIS\/JIT105","journal-title":"J Infect Dis"},{"key":"18_CR60","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/CID\/CIT703","volume":"58","author":"ME Wilson","year":"2014","unstructured":"Wilson ME, Hughes JM, McCollum AM, Damon IK (2014) Human monkeypox. Clin Infect Dis 58:260\u2013267. https:\/\/doi.org\/10.1093\/CID\/CIT703","journal-title":"Clin Infect Dis"}],"container-title":["Advances in Experimental Medicine and Biology","Poxviruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-57165-7_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T07:06:16Z","timestamp":1716793576000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-57165-7_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9783031571640","9783031571657"],"references-count":61,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-57165-7_18","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"28 May 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}